Growing community of inventors

Irvington, NY, United States of America

Cindy Gerson

Average Co-Inventor Count = 13.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 55

Cindy GersonAndrew J Murphy (5 patents)Cindy GersonGeorge D Yancopoulos (5 patents)Cindy GersonWilliam C Olson (5 patents)Cindy GersonGang Chen (5 patents)Cindy GersonNeil E Stahl (5 patents)Cindy GersonChristos Kyratsous (5 patents)Cindy GersonTammy T Huang (5 patents)Cindy GersonRobert Babb (5 patents)Cindy GersonAlina Baum (5 patents)Cindy GersonWen-Yi Lee (5 patents)Cindy GersonMarine Malbec (5 patents)Cindy GersonJohanna Hansen (5 patents)Cindy GersonWen-yi Lee (0 patent)Cindy GersonGang Chen (1 patent)Cindy GersonCindy Gerson (5 patents)Andrew J MurphyAndrew J Murphy (349 patents)George D YancopoulosGeorge D Yancopoulos (200 patents)William C OlsonWilliam C Olson (83 patents)Gang ChenGang Chen (70 patents)Neil E StahlNeil E Stahl (53 patents)Christos KyratsousChristos Kyratsous (35 patents)Tammy T HuangTammy T Huang (34 patents)Robert BabbRobert Babb (22 patents)Alina BaumAlina Baum (9 patents)Wen-Yi LeeWen-Yi Lee (6 patents)Marine MalbecMarine Malbec (5 patents)Johanna HansenJohanna Hansen (5 patents)Wen-yi LeeWen-yi Lee (0 patent)Gang ChenGang Chen (24 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Regeneron Pharmaceuticals, Inc. (5 from 1,343 patents)


5 patents:

1. 12251440 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

2. 11732030 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

3. 10975139 - Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

4. 10954289 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

5. 10787501 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…